An acute rise in intraluminal pressure shifts the mediator of flow-mediated dilation from nitric oxide to hydrogen peroxide in human arterioles

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 307, Issue 11, 2014, Pages H1587-H1593

  Beyer, Andreas M ^a   Durand, Matthew J ^a   Hockenberry, Joseph ^a   Gamblin, T Clark ^a   Phillips, Shane A ^b   Gutterman, David D ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Flow mediated dilation; Mitochondria; Reactive oxygen species; Vascular endothelium

Indexed keywords

2 (4 CARBOXYPHENYL) 4,4,5,5 TETRAMETHYLIMIDAZOLINE 1 OXYL 3 OXIDE; CATALASE; HYDROGEN PEROXIDE; MACROGOL; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; ROTENONE; SEPIAPTERIN; TEMPOL; PTERIN DERIVATIVE; SUPEROXIDE;

ADIPOSE TISSUE; ADULT; ARTERIOLE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; FLOW MEDIATED DILATION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN TISSUE; INTESTINE PRESSURE; MALE; MITOCHONDRION; VASODILATATION; BLOOD PRESSURE; DRUG EFFECTS; HEART MITOCHONDRION; IN VITRO STUDY; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ARTERIOLES; BLOOD PRESSURE; FEMALE; HUMANS; HYDROGEN PEROXIDE; IN VITRO TECHNIQUES; MALE; MIDDLE AGED; MITOCHONDRIA, HEART; NITRIC OXIDE; PTERINS; REACTIVE OXYGEN SPECIES; SUPEROXIDES; VASODILATION;

EID: 84913573408     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00557.2014     Document Type: Article

References (40)

1. Channon K. Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease. Trends Cardiovasc Med14: 323–327, 2004.
2. Chen CA, Wang TY, Varadharaj S, Reyes LA, Hemann C, Talukder MH, Chen YR, Druhan LJ, Zweier JL. S-glutathionylation uncouples eNOS and regulates its cellular and vascular function. Nature468: 1115–1118, 2010.
3. Chlopicki S, Kozlovski VI, Lorkowska B, Drelicharz L, Gebska A. Compensation of endothelium-dependent responses in coronary circulation of eNOS-deficient mice. J Cardiovasc Pharmacol46: 115–123, 2005.
4. Cooke M, John P, Dzau M, Victor J. Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med48: 489–509, 1997.
5. Dickinson BC, Chang CJ. A targetable fluorescent probe for imaging hydrogen peroxide in the mitochondria of living cells. J Am Chem Soc130: 9638–9639, 2008.
6. Dickinson BC, Lin VS, Chang CJ. Preparation and use of MitoPY1 for imaging hydrogen peroxide in mitochondria of live cells. Nat Protoc8: 1249–1259, 2013.
7. Dikalov SI, Kirilyuk IA, Voinov M, Grigor’ev IA. EPR detection of cellular and mitochondrial superoxide using cyclic hydroxylamines. Free Radic Res45: 417–430, 2011.
8. Durand MJ, Gutterman DD. Diversity in mechanisms of endothelium-dependent vasodilation in health and disease. Microcirculation20: 239–247, 2013.
9. Durand MJ, Phillips SA, Widlansky ME, Otterson MF, Gutterman DD. The vascular renin angiotensin system contributes to blunted vaso-dilation induced by transient high pressure in human adipose microvessels. Am J Physiol Heart Circ Physiol307: H25–H32, 2014.
10. Erusalimsky JD, Moncada S. Nitric oxide and mitochondrial signaling from physiology to pathophysiology. Arterioscler Thromb Vasc Biol27: 2524–2531, 2007.
11. Förstermann U, Münzel T. Endothelial nitric oxide synthase in vascular disease from marvel to menace. Circulation113: 1708–1714, 2006.
12. Freed JK, Beyer AM, LoGiudice JA, Hockenberry JC, Gutterman DD. Ceramide changes the mediator of flow-induced vasodilation from nitric oxide to hydrogen peroxide in the human microcirculation. Circ Res115: 525–532, 2014.
13. Gödecke A, Schrader J. Adaptive mechanisms of the cardiovascular system in transgenic mice-lessons from eNOS and myoglobin knockout mice. Basic Res Cardiol95: 492–498, 2000.
14. Gokce N, Keaney JF, Jr., Hunter LM, Watkins MT, Menzoian JO, Vita JA. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation105: 1567–1572, 2002.
15. Harrison D, Freiman P, Armstrong M, Marcus M, Heistad D. Alterations of vascular reactivity in atherosclerosis. Circ Res61: II74–180, 1987.
16. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, Lüscher TF. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation91: 1314-1319, 1995.
17. Jurva JW, Phillips SA, Syed AQ, Syed AY, Pitt S, Weaver A, Gutterman DD. The effect of exertional hypertension evoked by weight lifting on vascular endothelial function. J Am Coll Cardiol48: 588-589, 2006.
18. Kang KT, Sullivan JC, Sasser JM, Imig JD, Pollock JS. Novel nitric oxide synthase-dependent mechanism of vasorelaxation in small arteries from hypertensive rats. Hypertension49: 893-901, 2007.
19. Kang KT, Sullivan JC, Spradley FT, d’Uscio LV, Katusic ZS, Pollock JS. Antihypertensive therapy increases tetrahydrobiopterin levels and NO/cGMP signaling in small arteries of angiotensin II-infused hypertensive rats. Am J Physiol Heart Circ Physiol300: H718-H724, 2011.
20. Köttgen M, Buchholz B, Garcia-Gonzalez MA, Kotsis F, Fu X, Doerken M, Boehlke C, Steffl D, Tauber R, Wegierski T. TRPP2 and TRPV4 form a polymodal sensory channel complex. J Cell Biol182: 437–447, 2008.
21. Kuo L, Arko F, Chilian WM, Davis MJ. Coronary venular responses to flow and pressure. Circ Res72: 607-615, 1993.
22. Kuo L, Chilian WM, Davis MJ. Interaction of pressure- and flow-induced responses in porcine coronary resistance vessels. Am J Physiol Heart Circ Physiol261: H1706-H1715, 1991.
23. Kuo L, Davis MJ, Cannon MS, Chilian WM. Pathophysiological consequences of atherosclerosis extend into the coronary microcirculation. Restoration of endothelium-dependent responses by L-arginine. Circ Res70: 465-476, 1992.
24. Lind L. Endothelium-dependent vasodilation in hypertension: a review. Blood Press9: 4-15, 2000.
25. Liu Y, Bubolz AH, Mendoza S, Zhang DX, Gutterman DD. H2O2 is the transferrable factor mediating flow-induced dilation in human coronary arterioles. Circ Res108: 566-573, 2011.
26. Liu Y, Zhao H, Li H, Kalyanaraman B, Nicolosi AC, Gutterman DD. Mitochondrial sources of H2O2 generation play a key role in flow-mediated dilation in human coronary resistance arteries. Circ Res93: 573-580, 2003.
27. Mendoza SA, Fang J, Gutterman DD, Wilcox DA, Bubolz AH, Li R, Suzuki M, Zhang DX. TRPV4-mediated endothelial Ca2+ influx and vasodilation in response to shear stress. Am J Physiol Heart Circ Physiol298: H466-H476, 2010.
28. Miura H, Liu Y, Gutterman DD. Human coronary arteriolar dilation to bradykinin depends on membrane hyperpolarization contribution of nitric oxide and Ca2+-activated K+ channels. Circulation99: 3132-3138, 1999.
29. Mullen MJ, Kharbanda RK, Cross J, Donald AE, Taylor M, Vallance P, Deanfield JE, MacAllister RJ. Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo relevance to endothelial dysfunction in hypercholesterolemia. Circ Res88: 145–151, 2001.
30. Nauli SM, Jin X, Hierck BP. The mechanosensory role of primary cilia in vascular hypertension. Int J Vasc Med2011: 376281, 2011.
31. Ohsaki Y, O’Connor P, Mori T, Ryan RP, Dickinson BC, Chang CJ, Lu Y, Ito S, Cowley AW. Increase of sodium delivery stimulates the mitochondrial respiratory chain H2O2 production in rat renal medullary thick ascending limb. Am J Physiol Renal Physiol302: F95–F102, 2012.
32. Paniagua OA, Bryant MB, Panza JA. Role of endothelial nitric oxide in shear stress-induced vasodilation of human microvasculature diminished activity in hypertensive and hypercholesterolemic patients. Circulation103: 1752–1758, 2001.
33. Phillips SA, Das E, Wang J, Pritchard K, Gutterman DD. Resistance and aerobic exercise protects against acute endothelial impairment induced by a single exposure to hypertension during exertion. J Appl Physiol110: 1013–1020, 2011.
34. Phillips SA, Hatoum O, Gutterman DD. The mechanism of flow-induced dilation in human adipose arterioles involves hydrogen peroxide during CAD. Am J Physiol Heart Circ Physiol292: H93–H100, 2007.
35. Phillips SA, Jurva JW, Syed AQ, Kulinski JP, Pleuss J, Hoffmann RG, Gutterman DD. Benefit of low-fat over low-carbohydrate diet on endothelial health in obesity. Hypertension51: 376–382, 2008.
36. Sato A, Sakuma I, Gutterman DD. Mechanism of dilation to reactive oxygen species in human coronary arterioles. Am J Physiol Heart Circ Physiol285: H2345–H2354, 2003.
37. Touyz R, Schiffrin E. Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol122: 339–352, 2004.
38. Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension what is the clinical significance? Hypertension44: 248–252, 2004.
39. Yoshida T, Kawano H, Miyamoto S, Motoyama T, Fukushima H, Hirai N, Ogawa H. Prognostic value of flow-mediated dilation of the brachial artery in patients with cardiovascular disease. Intern Med45: 575–579, 2006.
40. Zinkevich NS, Gutterman DD. ROS-induced ROS release in vascular biology: redox-redox signaling. Am J Physiol Heart Circ Physiol301: H647–H653, 2011.